Frequency
Analysts on Wall Street consider the $89-a-share offer a low-ball bid; it could spur further M&A activity in the sector, however.
10:30AM 07/21/08
The drug failed to benefit patients with lupus, according to new late-stage study data.
10:12AM 04/29/08
The biotech giant looks to widen its focus to Alzheimer's drugs. Plus, other highlights from its annual meeting.
10:10AM 03/17/08
MannKind slumps on a downgrade.
5:36PM 03/10/08
CRA International falls on disappointing guidance.
3:25PM 03/10/08
Curis slumps on news P&G is ending their collaboration.
10:22PM 08/06/07
Novogen is on the rise.
3:35PM 09/18/06
Immune Response tumbles after getting 'going concern' clause.
4:57PM 04/04/05
Our Experts' Take at RealMoney
However, option traders boost January calls.
4:37PM 11/21/08
This market is producing a few stocks that could represent exceptional opportunities.
3:03PM 11/21/08
More Experts' Takes
More popular tickers are indicated by scale.
